Peer review and the process of publishing of adverse drug event reports

Journal of Forensic and Legal Medicine

Volumn 14, Issue 2, 2007, Pages 79-84

  Karch, Steven B ^a  

^a NONE   (United States)

Author keywords

Case report; Case series; Hearsay evidence; Junk science; Naranjo; Randomized clinical trials; Toxic torts

Indexed keywords

ACETYLSALICYLIC ACID; AMPHETAMINE; CANNABINOID; DOPAMINE; EPHEDRINE; FLUOXETINE; METHAMPHETAMINE; NORADRENALIN; PARACETAMOL; ROFECOXIB; STEROID;

ALGORITHM; ANALYTICAL ERROR; BRAIN EMBOLISM; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAREER; CAUSE OF DEATH; CHILD DEATH; COURT; DRUG FATALITY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; FETUS DEATH; FORGERY; HEADACHE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INDUSTRIALIZATION; MEDICAL LITERATURE; PEER REVIEW; PUBLISHING; QUALITY CONTROL; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; STROKE; TOXICITY TESTING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; FORENSIC MEDICINE; HUMANS; PEER REVIEW, RESEARCH; PHARMACEUTICAL PREPARATIONS; SCIENTIFIC MISCONDUCT;

EID: 33846349936     PISSN: 1752928X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcfm.2006.02.022     Document Type: Review

References (26)

1. DeBakey L., and DeBakey S. The case report. I. Guidelines for preparation. Int J Cardiol 4 3 (1983) 357-364
2. Kelly W. The quality of published adverse event reports. Ann Pharmacother 37 12 (2003) 1774-1778
3. Isner J.M., Estes III N.A., Thompson P.D., et al. Acute cardiac events temporally related to cocaine abuse. New Engl J Med 315 23 (1986) 1438-1443
4. Hollingsworth J.G., and Lasker E.G. The case against differential diagnosis: Daubert, medical causation testimony, and the scientific method. J Health Law 37 1 (2004) 85-111
5. Libman R.B., Menna B.L., and Gulati S. Case report: consequences of ephedra use in an athlete. Lancet 366 Suppl. 1 (2005) S22
6. Chen-Scarabelli C., Hughes S.E., Landon G., et al. A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. Eur J Heart Fail 7 5 (2005) 927-930
7. Szakacs J.E., Dimmette R.M., and Cowart Jr. E.C. Pathologic implication of the catechol amines, epinephrine and norepinephrine. US Armed Forces Med J 10 (1959) 908-925
8. Szakacs J.E., and Cannon A. l-Norepinephrine myocarditis. Am J Clin Pathol 30 5 (1958) 425-434
9. Kuhl U., Pauschinger M., Bock T., et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108 8 (2003) 945-950
10. Hardman J., Limbird L., and Goodman A. Pharmacokinetics. In: Wilkinson G. (Ed). Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. (2001), McGraw-Hill Medical Publishing Division, New York, Chicago, San Francisco, Lisbon, London, Madrid, Mexico City, Milan, New Selhi, San Juan Seoul, Singapore, Sydney, Toronto 3-30
11. Libman R., Menna B., and Gulati S. Case report: consequences of ephedra use in an athlete. Lancet 366 Suppl. 1 (2005) S22
12. Morgenstern L.B., Viscoli C.M., Kernan W.N., et al. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology 60 1 (2003) 132-135
13. Ariagno R., Karch S.B., Middleberg R., Stephens B.G., and Valdes-Dapena M. Methamphetamine ingestion by a breast-feeding mother and her infant's death: People v Henderson. JAMA 274 3 (1995) 215
14. Anon. Mother convicted for breast milk drug death of 3-month-old child. San Francisco Chronicle; 2003.
15. Stewart J.L., and Meeker J.E. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 21 6 (1997) 515-517
16. Anon. Patterns of medication use in the United States, 2004 (2004), Sloan Epidemiology Center, Boton University, Boston
17. Association AH. American Heart Association's Heart Disease and Stroke Statistics - 2004 update. Dallas 2004.
18. Wadman M. Journal grows suspicious of Vioxx data. Nature 438 (2005) 899
19. Curfman G., Morrissey S., and Drazen J. Expression of concern: Bombardier et al., "Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis". New Engl J Med 343 (2000) 1520-1528
20. NEJM 353 (2005) 26
21. Bradford-Hill A. The environment and disease: association or causation? President's address. Proc Roy Soc Med 9 (1965) 295-300
22. Dryer O. Consultant struck off for fraudulent claims. BMJ 310 (2005) 1554-1555
23. White C. Suspected research fraud: difficulties of getting at the truth. BMJ 331 7511 (2005) 281-288
24. Hawthorne G., Irgens L., Lie R., et al. Retraction of paper on maternal diabetes. BMJ 327 (2003) 7420-7429
25. Haller C.A., and Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. New Engl J Med 343 25 (2000) 1833-1838
26. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 2 (1981) 239-245